EN DE
Watch Caring Brands, Inc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Caring Brands, Inc (CABR) fair value: what the stock is really worth

As of Nov 5, 2026: fair value (intrinsic value) of Caring Brands, Inc stock $0.20, price $0.75, that is 73.3% below the price, quality 60 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare US

CB Caring Brands, Inc logo Thin data Nov 5, 2026

Caring Brands, Inc

CABR · US
Very expensive, in a downtrend

Our calculation puts a fair price 73% below what the stock costs today.

Quality 60/100
Revenue last quarter 10% below a year ago.
Fair value $0.2000 · Strongly overvalued (−73.3%)
Weak Growth
Negative free cash flow
Trails peers (1/5)
Narrow moat 12/100 · thin data
Downbeat coverage
Thin data
Watch Caring Brands, Inc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$5.65 $0.7450 Fair Value $0.2000 Jun 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.

How to read this chart

17‑month range $0.7450 – $5.65 · fair‑value band $0.1300 – $0.2500 · the $0.7500 price screens above the $0.2000 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.

Follow Caring Brands in your weekly email

Every Wednesday you see whether Caring Brands is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products.

Show moreShow less

It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; and CB-101 (Eczema Treatment) for atopic dermatitis (eczema).

The company also offers NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics, as well as provides vitiligo solutions and women's sexual wellness products. Caring Brands, Inc., was incorporated in 2020 and is based in Fort Pierce, Florida.

Stock analysis

Caring Brands, Inc (CABR) currently trades at $0.7500, while our model-based Fair Value estimate is $0.2000, 73% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 88/100, which puts the data coverage at low.

Scenario range: $0.1300 (bear) to $0.2500 (bull), the price of $0.7500 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Caring Brands, Inc reported revenue of $4.2K in FY2025 versus $20.4K in FY2023, a compound −54.6%/yr. Reported net income was −$6.3M in FY2025.

Key figures

Market cap $12.4M Micro · EPS (TTM) $−0.7800 · Return on equity −334% · Return on assets (EBIT) −318% · Operating margin −392,264% · Revenue growth (YoY) −9.7% · Free cash flow −$1.7M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).

What moves the price

The share trades about 87% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −73%, CABR screens richer than that median.

Fair Value models

Bear $0.1300 Fair Value $0.2000 Bull $0.2500
Price $0.7500 · Downside -73.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) $0.1300 $0.2000 $0.2500 52
All 1 models by family
Asset-Based
NCAV (Graham) $0.1300 $0.2000 $0.2500 52

Open the full fair value analysis →

Quality Score breakdown

Overall quality 60/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 70
Are margins and returns getting better?
Cashflow 25
Do the profits arrive as real cash?
Financial strength 100
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 0
How calm the share price moves, does not count
Price momentum 4
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 100
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, no officer or director bought or sold shares on the open market.

Plus one other filing such as a grant, option exercise or tax withholding. It is not a market purchase or sale.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 5, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed

CABR screens overvalued: fair value 73% below the price. Compare with Merck KGaA →

Earlier news

News mood ⓘNews mood, the average tone of recent news (7 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Very negative
Recent news coverage is unusually downbeat.

Compare Caring Brands, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 552 stocks

Beats the industry median on 1/4 measures
Overall it trails its industry peers.
Valuation
Quality Score 60 · Above median
Fair Value upside −73.3% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −9.7% · Bottom 25%

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B 5.95× · Priciest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Zoetis Inc ZTS $82.11 $110.26 +34% vs CABR
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,829 ₹1,947 +6% vs CABR
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥50.19 ¥53.31 +6% vs CABR
Haleon plc HLN $9.15 $8.59 −6% vs CABR
Merck KGaA MRK €150.35 €109.18 −27% vs CABR
Galderma Group GALD CHF 195.15 CHF 109.26 −44% vs CABR
Takeda Pharmaceutical Company TAK $21.19 $11.34 −46% vs CABR
Teva Pharmaceutical Industries Limited TEVA $41.78 $20.75 −50% vs CABR
Sandoz Group SDZ CHF 83.62 CHF 39.70 −53% vs CABR
Divi's Laboratories Limited DIVISLAB ₹10,141 ₹1,567 −85% vs CABR

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Caring Brands, Inc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Caring Brands, Inc Fair Value". https://www.fairvalue-calculator.com/stock/CABR

Frequently asked questions

Is Caring Brands, Inc (CABR) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of $0.2000 versus a price of $0.7500, about 73% lower (overvalued).
What is the fair value of CABR?
Our model-based fair value for Caring Brands, Inc is $0.2000 (as of Nov 5, 2026), built from audited fundamentals. The current price: $0.7500.
What is the quality score of CABR?
Caring Brands, Inc has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Caring Brands, Inc (CABR)?
Our model-based price target is the fair value of $0.2000 (as of Nov 5, 2026) from 1 valuation models. Cautious scenario $0.1300, optimistic scenario $0.2500. It is a calculation from audited fundamentals, not an analyst target.
What is the Caring Brands, Inc stock forecast for 2026?
Our models put fair value at $0.2000, about 73% lower versus a price of $0.7500 (overvalued). Cautious scenario $0.1300, optimistic scenario $0.2500. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Caring Brands, Inc (CABR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Caring Brands, Inc it is $0.2000 per share (as of Nov 5, 2026), against a price of $0.7500. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Caring Brands, Inc stock overvalued or undervalued in 2026?
As of Nov 5, 2026, CABR trades above its calculated fair value: price $0.7500, fair value $0.2000, a gap of about −73% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CABR?
No. The price is what the market pays today ($0.7500); the fair value is what the company's own numbers justify ($0.2000). For Caring Brands, Inc the two are $0.5500 per share apart. That gap is exactly why we show both numbers side by side.
How much is Caring Brands, Inc worth?
The market values Caring Brands, Inc at about $12.4M (market capitalisation, as of Nov 5, 2026). Per share that is $0.7500; our models calculate a fair value of $0.2000 per share.
What do the bullish and bearish scenarios say about CABR?
Our models span a range for Caring Brands, Inc: cautious scenario $0.1300, base $0.2000, optimistic $0.2500 per share (as of Nov 5, 2026, price $0.7500). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Caring Brands, Inc (CABR)?
Balance-sheet figures for Caring Brands, Inc (as of Nov 5, 2026): return on equity −333.7%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is CABR from its 52-week high?
Caring Brands, Inc trades at $0.7500, about 87% below its 52-week high of $5.65 and 1% above the low of $0.7450 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of $0.2000 is for.
Which stocks are comparable to Caring Brands, Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Galderma Group, Teva Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Caring Brands, Inc stock attractive at the current price?
The data as of Nov 5, 2026: price $0.7500, calculated fair value $0.2000 (−73%), Quality Score 60/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CABR calculated?
We run Caring Brands, Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.2000, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Caring Brands, Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Caring Brands, Inc (CABR)?
The closing price on Nov 5, 2026 was $0.7500. Our model-based fair value is $0.2000, about 73% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Caring Brands, Inc right now?
The price sits above even our optimistic bull case ($0.2500). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($0.1300 to $0.2500) leaves room in how you read the outcome.

Key figures of Caring Brands, Inc

How large is the market capitalisation of Caring Brands, Inc (CABR)?
The market capitalisation of Caring Brands, Inc is $12.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Caring Brands, Inc (CABR)?
Earnings per share at Caring Brands, Inc are $−0.7800. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Caring Brands, Inc (CABR)?
The return on equity (ROE) of Caring Brands, Inc is −334% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Caring Brands, Inc (CABR)?
On an EBIT basis the return on assets of Caring Brands, Inc is −318% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Caring Brands, Inc (CABR)?
The operating margin of Caring Brands, Inc is −392,264% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Caring Brands, Inc (CABR)?
Revenue at Caring Brands, Inc is growing −9.7% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Caring Brands, Inc (CABR) generate?
The free cash flow of Caring Brands, Inc is −$1.7M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Caring Brands, Inc in the live analysis

One click puts Caring Brands, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.